Ventripoint Diagnostics Ltd. reported its participation at the 53rd annual meeting of the German Society for Thoracic, Heart and Vascular Surgery. The event, held February 19, was held in conjunction with the annual meeting of the German society for Paediatric Cardiology and Congenital Heart Defects in Hamburg, Germany. Ventripoint's transformative technology, which uses a patented A.I. to convert inferior ultrasound images into MRI-grade analysis of the heart, was demonstrated by PD Dr. K.T. Laser, who actively uses Ventripoint in his clinical practice.

As a thought leader in paediatric cardiology, Dr. Laser is using the Ventripoint VMS+ to image patients at the HDZ NRW Heart and Diabetes Center in Germany. Dr. Laser's has reported that Ventripoint is an effective diagnostic tool that allows enhanced echocardiograms of infants and adults to be available faster and at less cost than a cardiac MRI with equivalent volumetric results. Ventripoint's technology is now being used in leading hospitals in Europe, the UK, Canada, and the United States.

The Company is now focused on expanding the user base of VMS+ in hospitals and clinics worldwide.